Understanding Ischemic Strokes in Patients on NOACs
Ischemic Strokes While on NOAC - How Compliance Matters
Chinese University of Hong Kong · NCT04607070
This study looks at how ischemic strokes affect adults with atrial fibrillation who are taking new blood thinners to see what causes these strokes and how they can be better treated.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 870 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong (other) |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT04607070 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the epidemiological trends, causes, clinical characteristics, and treatment options for ischemic strokes occurring in patients on novel oral anticoagulants (NOACs). Data will be collected from the stroke registry at Prince of Wales Hospital, focusing on adult patients with atrial fibrillation who experienced ischemic strokes or transient ischemic attacks over five specific years. The study will categorize patients based on their anticoagulation status and gather comprehensive demographic, clinical, and imaging data to identify preventable causes and inform future healthcare strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are ethnic Chinese adults with atrial fibrillation who have suffered an ischemic stroke.
Not a fit: Patients who are non-ethnic Chinese or those who have experienced a hemorrhagic stroke will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of ischemic strokes in patients on NOACs, leading to improved prevention and treatment strategies.
How similar studies have performed: While there may be studies on strokes and anticoagulants, this specific focus on ischemic strokes in the context of NOAC compliance is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients who were ethnic Chinese 2. Patients with known AF 3. Patient who suffered from ischaemic stroke Exclusion Criteria: 1. Patient who are non-ethnic Chinese 2. Patient who suffered from haemorrhagic stroke
Where this trial is running
Hong Kong
- Chinese University of Hong Kong — Hong Kong, Hong Kong (RECRUITING)
Study contacts
- Principal investigator: Yiu Ming Bonaventure IP, MBChB, MRCP — Chinese University of Hong Kong
- Study coordinator: Yiu Ming Bonaventure IP, MRCP
- Email: iym984@ha.org.hk
- Phone: 852-35053856
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke, Ischemic, Stroke, Acute, Stroke Syndrome, Stroke, Cardiovascular, Atherosclerosis, Ischemic Stroke, stroke, NOAC